{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:37Z","timestamp":1792691437505,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clineuro.2025.108786","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:03:27Z","timestamp":1739952207000},"page":"108786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Argatroban plus dual antiplatelet therapy: Preliminary evidence for managing early neurological deterioration after lacunar stroke"],"prefix":"10.1016","volume":"250","author":[{"given":"Haiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongna","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12883-022-02737-8","article-title":"Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis-data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)","volume":"22","author":"Che","year":"2022","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2025.108786_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaneurol.2018.1893","article-title":"FAST-MAG Trial coordinators and investigators. frequency, predictors, and outcomes of prehospital and early postarrival neurological deterioration in acute stroke: exploratory analysis of the FAST-MAG randomized clinical trial","volume":"75","author":"Shkirkova","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2014.05.038","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke","volume":"22","author":"He","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108786_bib4","first-page":"85","article-title":"Dual antiplatelet therapy in the management of acute minor ischemic stroke and high-risk transient ischemic attack: an expert consensus statement from Taiwan Stroke Society and Taiwan Society of Emergency Medicine","volume":"12","author":"Chen","year":"2022","journal-title":"J. Acute Med."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108786_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5853\/jos.2024.02250","article-title":"Early neurological deterioration and time to start dual antiplatelet therapy in patients with acute mild-to-moderate ischemic stroke: a pre-specified post hoc analysis of the ATAMIS trial","volume":"26","author":"Cui","year":"2024","journal-title":"J. Stroke"},{"issue":"6","key":"10.1016\/j.clineuro.2025.108786_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","article-title":"ARTSS-2 investigators. randomized, multicenter trial of ARTSS-2 (Argatroban with recombinant tissue plasminog- en activator for acute stroke)","volume":"48","author":"Barreto","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.108786_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1364895","article-title":"Efficacy and safety of Argatroban in patients with acute ischemic stroke: a systematic review and meta-analysis","volume":"15","author":"Cheng","year":"2024","journal-title":"Front Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2025.108786_bib8","first-page":"2088","article-title":"Advances in pharmacology and clinical application of argatroban","volume":"44","author":"Han","year":"2021","journal-title":"Drug Eval. Res."},{"issue":"9","key":"10.1016\/j.clineuro.2025.108786_bib9","first-page":"946","article-title":"Chinese expert consensus on the treatment of acute ischemic stroke with agatreban 2021","volume":"16","author":"Liu","year":"2021","journal-title":"Chin. J. Stroke"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108786_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000117444","article-title":"Cerebrovascular disease as the initial clinical presentation of haematological disorders","volume":"37","author":"Arboix","year":"1997","journal-title":"Eur. Neurol."},{"issue":"16","key":"10.1016\/j.clineuro.2025.108786_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators","volume":"279","year":"1998","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.clineuro.2025.108786_bib12","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.3390\/ijms23169476","article-title":"Molecular mechanisms and pathophysiology of acute stroke: emphasis on biomarkers in the different stroke subtypes","volume":"23","author":"Gasull","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108786_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/STROKEAHA.111.625574","article-title":"The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study","volume":"43","author":"Barreto","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.108786_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108786_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jamaneurol.2023.5093","article-title":"Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial","volume":"81","author":"Zhang","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2025.108786_bib16","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/01.STR.0000177872.87960.61","article-title":"Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials","volume":"36","author":"Uyttenboogaart","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108786_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nic.2007.03.001","article-title":"Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease","volume":"17","author":"Derdeyn","year":"2007","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108786_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.02.006","article-title":"Topographic patterns and stroke subtypes according to progressive motor deficits in lacunar syndrome","volume":"20","author":"Kim","year":"2011","journal-title":"J. Stroke Cereb. Dis."},{"issue":"1-2","key":"10.1016\/j.clineuro.2025.108786_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0304-3940(01)02260-1","article-title":"Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24h of human acute ischemic stroke","volume":"313","author":"McConnell","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108786_bib20","first-page":"368","article-title":"The role of thrombin in central nervous system activity and stroke","volume":"91","author":"Ple\u015feru","year":"2018","journal-title":"Clujul Med."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/ijms17010084","article-title":"The importance of thrombin in cerebral injury and disease","volume":"17","author":"Krenzlin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.clineuro.2025.108786_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2664","article-title":"Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis","volume":"12","author":"Li","year":"2022","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108786_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298226","article-title":"Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression","volume":"19","author":"Xie","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108786_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.12998\/wjcc.v10.i2.585","article-title":"Efficacy and safety of argatroban in treatment of acute ischemic stroke: a meta-analysis","volume":"10","author":"LV","year":"2022","journal-title":"World J. Clin. Cases"},{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015368126304","article-title":"Argatroban","volume":"13","author":"Kathiresan","year":"2002","journal-title":"J. Thromb. Thrombolysis"},{"issue":"5","key":"10.1016\/j.clineuro.2025.108786_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000351753","article-title":"Comparison of the European and Japanese guidelines for the management of ischemic stroke","volume":"35","author":"Kern","year":"2013","journal-title":"Cereb. Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108786_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00415-006-0365-y","article-title":"Japan Standard Stroke Registry Study Group. Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke","volume":"254","author":"Hosomi","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108786_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620904131","article-title":"Effect of argatroban combined with dual antiplatelet therapy on early neurological deterioration in acute minor posterior circulation ischemic stroke","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib29","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1161\/STROKEAHA.121.036356","article-title":"Dual antiplatelet therapy plus argatroban prevents early neurological deterioration in branch atherosclerosis disease","volume":"53","author":"Xu","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2025.108786_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2020.04.003","article-title":"ARAIS Protocol Steering Group. Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): rationale and design","volume":"225","author":"Yang","year":"2020","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108786_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12883-022-02861-5","article-title":"Risk factors for early neurological deterioration in acute isolated pontine infarction without any causative artery stenosis","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108786_bib32","first-page":"557","article-title":"Safety of dual antiplatelet therapy with argatroban in patients with acute ischemic stroke","volume":"70","author":"Nagakane","year":"2018","journal-title":"Brain Nerve"},{"issue":"12","key":"10.1016\/j.clineuro.2025.108786_bib33","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.036","article-title":"Safety and feasibility of argatroban, recombinant tissue plasminogen activator, and intra-arterial therapy in stroke (ARTSS-IA Study)","volume":"27","author":"Berekashvili","year":"2018","journal-title":"J. Stroke Cereb. Dis."},{"issue":"7","key":"10.1016\/j.clineuro.2025.108786_bib34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5551\/jat.RV22003","article-title":"Pathophysiology and optimal treatment of intracranial branch atheromatous disease","volume":"30","author":"Deguchi","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108786_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000319460","article-title":"Nineteen-year trends in risk factors, clinical characteristics and prognosis in lacunar infarcts","volume":"35","author":"Arboix","year":"2010","journal-title":"Neuroepidemiology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:39:35Z","timestamp":1741459175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S0303846725000691"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108786","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Argatroban plus dual antiplatelet therapy: Preliminary evidence for managing early neurological deterioration after lacunar stroke","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108786"}}